Despite higher levels of vascular VEGFR2 expression in tumor vasculature in HER2+ BRCs, overall, only a smaller proportion (8%) of BRC tissues in this analysis showed cytoplasmic and/or membrane expression of VEGFR2 protein in invasive carcinoma cells. The gene discussed is ERBB2; the disease is invasive carcinoma.